Logo image of CRCL

CIRCLE INTERNET GROUP INC (CRCL) Stock Fundamental Analysis

NYSE:CRCL - US1725731079 - Common Stock

131.695 USD
+0.75 (+0.58%)
Last: 8/29/2025, 10:25:10 AM
Fundamental Rating

2

Taking everything into account, CRCL scores 2 out of 10 in our fundamental rating. CRCL was compared to 0 industry peers in the Unkown industry. CRCL may be in some trouble as it scores bad on both profitability and health. CRCL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CRCL was profitable.
CRCL Yearly Net Income VS EBIT VS OCF VS FCFCRCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

Industry RankSector Rank
ROA 0.24%
ROE 6.57%
ROIC 5.03%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRCL Yearly ROA, ROE, ROICCRCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 5 10 15

1.3 Margins

Industry RankSector Rank
OM 10.11%
PM (TTM) 9.29%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRCL Yearly Profit, Operating, Gross MarginsCRCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -20 -40 -60 -80

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRCL is destroying value.
CRCL has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for CRCL has been reduced compared to a year ago.
CRCL Yearly Shares OutstandingCRCL Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 50M 100M 150M 200M
CRCL Yearly Total Debt VS Total AssetsCRCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 10B 20B 30B 40B

2.2 Solvency

CRCL has an Altman-Z score of 0.32. This is a bad value and indicates that CRCL is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.09 indicates that CRCL is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 0.32
ROIC/WACC0.5
WACC10.02%
CRCL Yearly LT Debt VS Equity VS FCFCRCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

CRCL has a Current Ratio of 1.03. This is a normal value and indicates that CRCL is financially healthy and should not expect problems in meeting its short term obligations.
CRCL has a Quick Ratio of 1.03. This is a normal value and indicates that CRCL is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
CRCL Yearly Current Assets VS Current LiabilitesCRCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 10B 20B 30B 40B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CRCL have decreased strongly by -41.80% in the last year.
The Revenue has grown by 15.57% in the past year. This is quite good.
EPS 1Y (TTM)-41.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)15.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CRCL will show a very strong growth in Earnings Per Share. The EPS will grow by 46.62% on average per year.
CRCL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 39.29% yearly.
EPS Next Y-71.97%
EPS Next 2Y34.74%
EPS Next 3Y46.62%
EPS Next 5YN/A
Revenue Next Year58.75%
Revenue Next 2Y37.78%
Revenue Next 3Y39.29%
Revenue Next 5YN/A

3.3 Evolution

CRCL Yearly Revenue VS EstimatesCRCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
CRCL Yearly EPS VS EstimatesCRCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.5 1 1.5 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 185.49, which means the current valuation is very expensive for CRCL.
CRCL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.17.
CRCL is valuated quite expensively with a Price/Forward Earnings ratio of 102.17.
The average S&P500 Price/Forward Earnings ratio is at 22.78. CRCL is valued rather expensively when compared to this.
Industry RankSector Rank
PE 185.49
Fwd PE 102.17
CRCL Price Earnings VS Forward Price EarningsCRCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 131.28
CRCL Per share dataCRCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as CRCL's earnings are expected to grow with 46.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.74%
EPS Next 3Y46.62%

More info and screens

0

5. Dividend

5.1 Amount

CRCL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CIRCLE INTERNET GROUP INC

NYSE:CRCL (8/29/2025, 10:25:10 AM)

131.695

+0.75 (+0.58%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)N/A N/A
Inst Owners46.85%
Inst Owner ChangeN/A
Ins Owners2.3%
Ins Owner Change-89.99%
Market Cap30.21B
Analysts72.73
Price Target191.25 (45.22%)
Short Float %3.32%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.92%
PT rev (3m)N/A
EPS NQ rev (1m)32%
EPS NQ rev (3m)N/A
EPS NY rev (1m)175.04%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-1.39%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)12.56%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 185.49
Fwd PE 102.17
P/S 18.03
P/FCF N/A
P/OCF N/A
P/B 12.74
P/tB 17.7
EV/EBITDA 131.28
EPS(TTM)0.71
EY0.54%
EPS(NY)1.29
Fwd EY0.98%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.31
BVpS10.33
TBVpS7.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.24%
ROE 6.57%
ROCE 6.99%
ROIC 5.03%
ROICexc 8.75%
ROICexgc 15.6%
OM 10.11%
PM (TTM) 9.29%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA 0.94
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z 0.32
F-ScoreN/A
WACC10.02%
ROIC/WACC0.5
Cap/Depr(3y)123.17%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.83%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-71.97%
EPS Next 2Y34.74%
EPS Next 3Y46.62%
EPS Next 5YN/A
Revenue 1Y (TTM)15.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year58.75%
Revenue Next 2Y37.78%
Revenue Next 3Y39.29%
Revenue Next 5YN/A
EBIT growth 1Y-30.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year192.55%
EBIT Next 3Y85.12%
EBIT Next 5YN/A
FCF growth 1Y171.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y147.18%
OCF growth 3YN/A
OCF growth 5YN/A